[Skip to Navigation]
Sign In
Comment & Response
February 2018

Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer

Author Affiliations
  • 1Department of Basic Medicine (Basic Medical Research), Inner Mongolia Medical University, Inner Mongolia, PR China
  • 2Department of Orthopedic Surgery and BME-Campbell Clinic, University of Tennessee Health Science Center, Memphis, Tennessee
  • 3Fourth Hospital, Hebei Medical University, Shijiazhuang, Hebei, PR China
JAMA Oncol. 2018;4(2):263. doi:10.1001/jamaoncol.2016.6615

To the Editor We read with great interest the article by Chu et al1 that describes the association of proton pump inhibitors and capecitabine efficacy in advanced gastroesophageal cancer. We agree with the authors that there are limitations to the study. Furthermore, together in viewing the previous publication regarding the same population,2 we believe that the study raised an issue regarding the difference in response to treatment with anti–human epidermal growth factor receptor 2 (HER2) drugs among cancer patients of different ethnic groups.

Add or change institution